Articles
  

Altered Pattern of Naïve and Memory B cells and B1 Cells in Patients with Chronic Granulomatous Disease

Abstract

Chronic  granulomatous  disease (CGD)  is a rare primary immunodeficiency disorder characterized by a greatly increased susceptibility to severe fungal and bacterial infections caused  by  defects  in  NADPH   oxidase  of  phagocytic  cells. We  aimed  to  investigate immunophenotype alterations of naïve and memory B cells and B1a cells in peripheral whole blood from Iranian patients with CGD.
Flow cytometric analysis was performed  on  peripheral blood  samples from  31 CGD patients and 23 healthy controls (HC) to study naïve (IgD+/CD27-), memory (CD27+) B and B1a (CD5+) cells. Soluble CD27 (sCD27) and immunoglobulins were also measured by ELISA and the nephelometric method, respectively.
We found significantly higher levels of naïve B cells and B1a cells but lower levels of memory B cells in CGD patients compared to HC. There was no significant difference in soluble CD27 (sCD27) alteration between CGD patients and HC.
Our findings suggested a role for NADPH oxidase in process of B cell differentiation and impairing conversion of naïve B cells to  memory B cells and altered B1a cells in CGD patients.  Increased   susceptibility  of   CGD   patients   to   opportunistic   infections   and autoimmune disorders could be partly explained by the altered phenotype of B lymphocytes in these patients.

1. Holmes B, Quie PG, Windhorst DB, Good RA. Fatal granulomatous disease of childhood. An inborn abnormality of phagocytic function. Lancet 1966;1(7449):1225-8.
2. Stasia MJ, Li XJ. Genetics and immunopathology of chronic granulomatous disease. Semin Immunopathol 2008; 30(3):209-35.
3. Segal BH, Leto TL, Gallin JI, Malech HL, Holland SM.Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine (Baltimore) 2000; 79(3):170-200.
4. Matute JD, Arias AA, Wright NA, Wrobel I, Waterhouse CC, Li XJ, et al. A new genetic subgroup of chronic granulomatous disease with autosomal recessive mutations in p40 phox and selective defects in neutrophil NADPH oxidase activity. Blood 2009; 114(15):3309-15.
5. Batot G, Paclet MH, Doussière J, Vergnaud S, Martel C, Vignais PV, et al. Biochemical and immunochemical properties of B lymphocyte cytochrome b558. Biochim Biophys Acta 1998; 1406(2):188-202.
6. Dorseuil O, Vazquez A, Lang P, Bertoglio J, Gacon G, Leca G. Inhibition of superoxide production in B lymphocytes by rac antisense oligonucleotides. J Biol Chem 1992; 267(29):20540-20542.
7. Izuhara K, Arinobu Y, Sumimoto H, Nunoi H, Takeya R, Higuchi K, et al. Association of the interleukin-4 receptor alpha chain with p47phox, an activator of the phagocyte NADPH oxidase in B cells. Mol Immunol 1999;36(1):45-52.
8. Grandvaux N, Elsen S, Vignais PV. Oxidant-dependent phosphorylation of p40phox in B lymphocytes. Biochem.Biophys. Res Commun 2001; 287(4):1009-16.
9. Dusi S, Nadalini KA, Donini M, Zentilin L, Wientjes FB, Roos D, et al. Nicotinamide-adenine dinucleotide phosphate oxidase assembly and activation in EBV- transformed B lymphoblastoid cell lines of normal and chronic granulomatous disease patients. J Immunol 1998;161(9):4968-74.
10. Agematsu K, Hokibara S, Nagumo H, Komiyama A.CD27: a memory B-cell marker. Immunol.Today 2000;21(5):204-6.
11. Maurer D, Fischer GF, Fae I, Majdic O, Stuhlmeier K, Von Jeney N, et al. IgM and IgG but not cytokine secretion is restricted to the CD27+ B lymphocyte subset. J Immunol 1992; 148(12):3700-5.
12. Borst J, Hendriks J, Xiao Y. CD27 and CD70 in T cell and B cell activation. Curr Opin Immunol. 2005; 17(3):275-81.
13. Agematsu K, Futatani T, Hokibara S, Kobayashi N, Takamoto M, Tsukada S, et al. Absence of memory B cells in patients with common variable immunodeficiency. Clin Immunol 2002; 103(1):34-42.
14. Salmen S, Corte D, Goncalves L, Barboza L, Montes H, Calderón A, et al. CD40/CD40L expression in leukocytes from chronic granulomatous disease patients. APMIS 2007; 115(8):939-47.
15. Mantovani L, Wilder RL, Casali P. Human rheumatoid B-1a (CD5+ B) cells make somatically hypermutated high affinity IgM rheumatoid factors. J Immunol 1993;151(1):473-88.
16. Mir Saeid Ghazi B, Aghamohammadi A, Kouhi A, Farhoudi A, Moin M, Rezaei N, et al. Mortality in primary immunodeficient patients, registered in Iranian primary immunodeficiency registry. Iran J Allergy Asthma Immunol 2004; 3(1):31-6.
17. Movahedi M, Aghamohammadi A, Farhoudi A, Moin M, Pourpak Z, Gharagozlou M, et al. Respiratory manifestations of chronic granulomatous disease; a clinical survey of patients from Iranian primary immunodeficiency registry. Iran J Allergy Asthma Immunol 2003; 2(1):45-51.
18. Fattahi F, Badalzadeh M, Sedighipour L, Movahedi M, Fazlollahi MR, Mansouri SD, et al. Inheritance pattern and clinical aspects of 93 Iranian patients with chronic granulomatous disease. J Clin Immunol 2011; 31(5):792-801.
19. Lentner C. Geigy Scientific Tables. Basle, Switzerland: Ciba Geigy Ltd, 1984:154.
20. Bleesing JJ, Souto-Carneiro MM, Savage WJ, Brown MR, Martinez C, Yavuz S, et al. Patients with chronic granulomatous disease have a reduced peripheral blood memory B cell compartment. J Immunol 2006;176(11):7096-103.
21. Jacquot S, Maçon-Lemaître L, Paris E, Kobata T, Tanaka Y, Morimoto C, et al. B cell co-receptors regulating T cell-dependent antibody production in common variable immunodeficiency: CD27 pathway defects identify subsets of severely immuno-compromised patients. Int Immunol 2001; 13(7):871-76.
22. Agematsu K, Nagumo H, Shinozaki K, Hokibara S, Yasui K, Terada K, et al. Absence of IgD-CD27(+) memory B cell population in X-linked hyper-IgM syndrome. J Clin Invest 1998; 102(4):853-60.
23. Berland R, Wortis HH. Origins and functions of B-1 cells with notes on the role of CD5. Annu Rev Immunol 2002;20:253-300.
24. Duan B, Morel L. Role of B-1a cells in autoimmunity.Autoimmun Rev 2006; 5(6):403-8.
25. Veneri D, Franchini M, Vella A, Tridente G, Semenzato G, Pizzolo G, et al. Changes of human B and B-1a peripheral blood lymphocytes with age. Hematology2007; 12(4):337-41.
26. Carnide EG, Jacob CA, Castro AC, Pastorino AC.Clinical and laboratory aspects of chronic granulomatous disease in description of eighteen patients. Pediatr Allergy Immunol 2005; 16(1):5-9.
27. Cale CM, Morton L, Goldblatt D. Cutaneous and other lupus-like symptoms in carriers of X-linked chronic granulomatous disease: incidence and autoimmune serology. Clin Exp Immunol 2007; 148(1):79-84.
28. Xu Z, Butfiloski EJ, Sobel ES, Morel L. Mechanisms of peritoneal B-1a cells accumulation induced by murine lupus susceptibility locus Sle2. J Immunol 2004;173(10):6050-8.
29. Bohnhorst JO, Bjorgan MB, Thoen JE, Jonsson R, Natvig JB, Thompson KM. Abnormal B cell differentiation in primary Sjogren's syndrome results in a depressed percentage of circulating memory B cells and elevated levels of soluble CD27 that correlate with Serum IgG concentration. Clin Immunol 2002; 103(1):79-88.

Files
IssueVol 13, No 3 (2014) QRcode
SectionArticles
Keywords
B-Lymphocytes Chronic granulomatous disease CD27 CD5 IgD Naïve B cells Memory B cells
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Mohsenzadegan M, Fattahi F, Fattahi F, Mirshafiey A, Fazlollahi MR, Naderi Beni F, Movahedi M, Pourpak Z. Altered Pattern of Naïve and Memory B cells and B1 Cells in Patients with Chronic Granulomatous Disease. Iran J Allergy Asthma Immunol. 1;13(3):157-165.